6505--Sources Sought VISN2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS

The Department of Veterans Affairs Veterans Health Administration, through VISN 2, seeks to identify manufacturers and distributors of radiopharmaceuticals in this pre-solicitation sources sought notice for VISN 2 Downstate General Radiopharmaceuticals, with responses due November 17, 2026 at 1600 EST. No set-aside is used, and the notice is not a formal solicitation or obligation. Responses go by email to Janelle.Bonafede@va.gov and must include firm name, socio-economic category, complete address, and contact phone and fax numbers. NAICS 325412 and PSC 6505 apply.

Scope covers diagnostic radiopharmaceuticals, therapeutic radiopharmaceuticals, radioactive quality assurance materials, and non-radioactive pharmaceuticals for delivery to VISN 2 Downstate medical centers. Contractors must provide 24/7 availability, routine deliveries three times daily Monday through Friday before 7 AM, 12 noon, and 2 PM, and two-hour emergency delivery. The notice requires greater than 95% on-time delivery performance, with penalties for missed doses, and sales representatives at each participating medical center.

Requirements include Nuclear Regulatory Commission licenses; compliance with FDA, DOT, OSHA, USP 797, and CFR Title 10; quality control testing and documentation; and HIPAA compliance. All radiopharmaceuticals must be made in America, and Technetium-99m unit doses must be derived from low-enriched uranium. Labels require radiation warnings, expiration dates, and barcode inserts compatible with the VA's nuclear medicine information management system. Products ship in shielded, labeled containers meeting federal and state radioactive material standards, and contractors provide spent syringe disposal systems meeting OSHA biohazard regulations. Upon award, contractors supply current quality control manuals, clean room compliance reports, and Material Safety Data Sheets for all products at no additional cost.